Patents Assigned to NSABP Foundations, Inc.
  • Gene expression markers for colorectal cancer prognosis
    Patent number: 8153378
    Abstract: A method of predicting clinical outcome in a subject diagnosed with colorectal cancer comprising determining evidence of the expression of one or more predictive RNA transcripts or their expression products in a biological sample of cancer cells obtained from the subject.
    Type: Grant
    Filed: January 29, 2010
    Date of Patent: April 10, 2012
    Assignees: Genomic Health, Inc., NSABP Foundations, Inc.
    Inventors: Wayne Cowens, Joffre B. Baker, Kim Clark, James Hackett, Drew Watson, Soonmyung Paik